Literature DB >> 22228974

Growth inhibitory effect of 4-phenyl butyric acid on human gastric cancer cells is associated with cell cycle arrest.

Long-Zhu Li1, Hong-Xia Deng, Wen-Zhu Lou, Xue-Yan Sun, Meng-Wan Song, Jing Tao, Bing-Xiu Xiao, Jun-Ming Guo.   

Abstract

AIM: To investigate the growth effects of 4-phenyl butyric acid (PBA) on human gastric carcinoma cells and their mechanisms.
METHODS: Moderately-differentiated human gastric carcinoma SGC-7901 and lowly-differentiated MGC-803 cells were treated with 5, 10, 20, 40, and 60 μmol/L PBA for 1-4 d. Cell proliferation was detected using the MTT colorimetric assay. Cell cycle distributions were examined using flow cytometry.
RESULTS: The proliferation of gastric carcinoma cells was inhibited by PBA in a dose- and time-dependent fashion. Flow cytometry showed that SGC-7901 cells treated with low concentrations of PBA were arrested at the G₀/G₁ phase, whereas cells treated with high concentrations of PBA were arrested at the G₂/M phase. Although MGC-803 cells treated with low concentrations of PBA were also arrested at the G₀/ G₁ phase, cells treated with high concentrations of PBA were arrested at the S phase.
CONCLUSION: The growth inhibitory effect of PBA on gastric cancer cells is associated with alteration of the cell cycle. For moderately-differentiated gastric cancer cells, the cell cycle was arrested at the G₀ /G₁ and G₂/M phases. For lowly-differentiated gastric cancer cells, the cell cycle was arrested at the G₀/G₁ and S phases.

Entities:  

Keywords:  4-phenyl butyric acid; Anticancer effect; Cell cycle; Gastric carcinoma; Histone deacetylase inhibitor; MGC-803; SGC-7901

Mesh:

Substances:

Year:  2012        PMID: 22228974      PMCID: PMC3251809          DOI: 10.3748/wjg.v18.i1.79

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  Cellular memory and the histone code.

Authors:  Bryan M Turner
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

2.  Phenylbutyrate-induced apoptosis is associated with inactivation of NF-kappaB IN HT-29 colon cancer cells.

Authors:  Rena Feinman; Kevin O Clarke; Lawrence E Harrison
Journal:  Cancer Chemother Pharmacol       Date:  2002-01       Impact factor: 3.333

Review 3.  Histone deacetylase inhibitors in myelodysplastic syndrome.

Authors:  Kapil Bhalla; Alan List
Journal:  Best Pract Res Clin Haematol       Date:  2004-12       Impact factor: 3.020

4.  Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth.

Authors:  Nerissa Mendoza; Sharon Fong; Jim Marsters; Hartmut Koeppen; Ralph Schwall; Dineli Wickramasinghe
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

5.  Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.

Authors:  Irina Svechnikova; Steven G Gray; Jurgita Kundrotiene; Frida Ponthan; Per Kogner; Tomas J Ekström
Journal:  Int J Oncol       Date:  2003-03       Impact factor: 5.650

6.  Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells.

Authors:  Xiao-Nan Li; Suhag Parikh; Qin Shu; Hye-Lim Jung; Chi-Wan Chow; Laszlo Perlaky; Hon-Chiu Eastwood Leung; Jack Su; Susan Blaney; Ching C Lau
Journal:  Clin Cancer Res       Date:  2004-02-01       Impact factor: 12.531

7.  Distinct roles for cyclin-dependent kinases in cell cycle control.

Authors:  S van den Heuvel; E Harlow
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

8.  Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA.

Authors:  Myoung Sook Kim; Mellissa Blake; Jin Hyen Baek; Glenda Kohlhagen; Yves Pommier; France Carrier
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

9.  DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers.

Authors:  A Satoh; M Toyota; F Itoh; T Kikuchi; T Obata; Y Sasaki; H Suzuki; A Yawata; M Kusano; M Fujita; M Hosokawa; K Yanagihara; T Tokino; K Imai
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

10.  Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer.

Authors:  R Kuefer; M D Hofer; V Altug; C Zorn; F Genze; K Kunzi-Rapp; R E Hautmann; J E Gschwend
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

View more
  11 in total

1.  Unfolded protein response (UPR) signaling regulates arsenic trioxide-mediated macrophage innate immune function disruption.

Authors:  Ritesh K Srivastava; Changzhao Li; Sandeep C Chaudhary; Mary E Ballestas; Craig A Elmets; David J Robbins; Sadis Matalon; Jessy S Deshane; Farrukh Afaq; David R Bickers; Mohammad Athar
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-14       Impact factor: 4.219

2.  Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients.

Authors:  Hailong Zhang; Yixuan Hou; Liyun Xu; Zongyue Zeng; Siyang Wen; Yan-E Du; Kexin Sun; Jiali Yin; Lei Lang; Xiaoli Tang; Manran Liu
Journal:  Dig Dis Sci       Date:  2015-12-22       Impact factor: 3.199

3.  Porcine Circovirus Type 2 Induces ORF3-Independent Mitochondrial Apoptosis via PERK Activation and Elevation of Cytosolic Calcium.

Authors:  Yikai Zhang; Renjie Sun; Shichao Geng; Ying Shan; Xiaoliang Li; Weihuan Fang
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

4.  Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches.

Authors:  Hung-Jin Huang; Olga A Kraevaya; Ilya I Voronov; Pavel A Troshin; Shan-Hui Hsu
Journal:  Int J Nanomedicine       Date:  2020-04-14

Review 5.  Potential for therapeutic manipulation of the UPR in disease.

Authors:  Sang Won Park; Umut Ozcan
Journal:  Semin Immunopathol       Date:  2013-04-10       Impact factor: 9.623

6.  Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells.

Authors:  Bo-Ra Lee; Sun-Young Chang; Eun-Hye Hong; Bo-Eun Kwon; Hong Min Kim; Yeon-Jeong Kim; Jongkook Lee; Hyun-Jong Cho; Jae-Hee Cheon; Hyun-Jeong Ko
Journal:  Oncotarget       Date:  2014-12-15

7.  Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D3.

Authors:  Anna K Coussens; Robert J Wilkinson; Adrian R Martineau
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

8.  Porcine Circovirus 2 Deploys PERK Pathway and GRP78 for Its Enhanced Replication in PK-15 Cells.

Authors:  Yingshan Zhou; Baozhu Qi; Yuanxing Gu; Fei Xu; Huahua Du; Xiaoliang Li; Weihuan Fang
Journal:  Viruses       Date:  2016-02-20       Impact factor: 5.048

9.  Chemical chaperone, TUDCA unlike PBA, mitigates protein aggregation efficiently and resists ER and non-ER stress induced HepG2 cell death.

Authors:  Jagadeesh Kumar Uppala; Amina R Gani; Kolluru V A Ramaiah
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

10.  Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line.

Authors:  Magdalena Kusaczuk; Rafał Krętowski; Marek Bartoszewicz; Marzanna Cechowska-Pasko
Journal:  Tumour Biol       Date:  2015-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.